| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/09/1998 | EP0862622A1 Rac-proteine kinase as therapeutic agent or in diagnostics |
| 09/09/1998 | EP0862620A1 Tyrosine kinase gene and gene product |
| 09/09/1998 | EP0862619A1 Pskh-1 ribozymes and uses in disease treatment |
| 09/09/1998 | EP0862615A1 Immunity against pasteurella haemolytica leukotoxin |
| 09/09/1998 | EP0862584A1 Production of antibodies, and medical uses involving antibodies |
| 09/09/1998 | EP0862580A1 Streptoccal inhibitor of complement-mediated lysis, protein sic |
| 09/09/1998 | EP0862579A1 Cyclohexapeptidyl bisamine compound, compositions containing said compound and methods of use |
| 09/09/1998 | EP0862578A1 Actinomycin d analogues |
| 09/09/1998 | EP0862461A1 Methods of treating established colitis using antibodies against il-12 |
| 09/09/1998 | EP0862460A1 Methods of reducing apolipoprotein e4-induced inhibition of neuron remodeling |
| 09/09/1998 | EP0862459A1 Uses of tfpi inhibitor for treatment of cancer |
| 09/09/1998 | EP0862458A1 Urease for the treatment of helicobacter pylori infections |
| 09/09/1998 | EP0862457A1 Infusions of neuroprotectants and thrombolytic agents |
| 09/09/1998 | EP0862456A1 Enzymatic method and compositions for treating intravitreal hemorrhagic blood |
| 09/09/1998 | EP0862455A1 Interferon-polymer conjugates and process for preparing the same |
| 09/09/1998 | EP0862454A1 Novel uses of mammalian ctla-8 and related reagents |
| 09/09/1998 | EP0862453A1 Bone morphogenetic protein and fibroblast growth factor compositions and methods for the induction of cardiogenesis |
| 09/09/1998 | EP0862452A1 Stabilizing formulation for ngf |
| 09/09/1998 | EP0862451A2 Composition for improving pancreatic function |
| 09/09/1998 | EP0862450A2 A method for inhibiting attachment of h. influenzae to human cells using phosphorylated recombinant human beta-casein |
| 09/09/1998 | EP0862449A1 Chemokine inhibitor |
| 09/09/1998 | EP0862448A1 Fine tuned protegrins |
| 09/09/1998 | EP0862447A1 Generating d-peptides: methods and compositions |
| 09/09/1998 | EP0862444A1 Treatment of cardiomyopathy by removal of autoantibodies |
| 09/09/1998 | EP0862440A1 Therapeutic use of hemoglobin in promoting wound healing |
| 09/09/1998 | EP0862429A1 Method of adjusting the circadian rhythm of a mammal |
| 09/09/1998 | EP0862418A1 Method of producing morphologically uniform microcapsules and microcapsules produced by this method |
| 09/09/1998 | EP0673419B1 Stably transfected cell lines expressing gaba-a receptors |
| 09/09/1998 | EP0651641B1 Novel bioactive compositions, preparation and use thereof |
| 09/09/1998 | EP0650498B1 Suppression of t-cell proliferation using peptide fragments of myelin basic protein |
| 09/09/1998 | EP0454813B1 A casein fraction for therapeutic, prophylactic and/or diagnostic use in infections of the respiratory tract |
| 09/09/1998 | CN1192781A Use of neuro-derived fetal cell lines for tranplantation therapy |
| 09/09/1998 | CN1192779A Monkey monoclonal antibodies specific to human b. 7.1 and/or B7.2 primatized forms, pharmaceutical compositions |
| 09/09/1998 | CN1192751A Monocype chemotactic protein-4 |
| 09/09/1998 | CN1192750A Cyclosporin derivatives with anti-HIV effect |
| 09/09/1998 | CN1192749A Peptide and compounds that bind to receptor |
| 09/09/1998 | CN1192748A Compounds and peptide that bind to the erythropoietin receptor |
| 09/09/1998 | CN1192747A Peptidyl heterocycles useful in the treatment of thrombin related disorders |
| 09/09/1998 | CN1192746A Peptide derivatives and angiotensin 5 receptor agonist |
| 09/09/1998 | CN1192733A Stable reagent for prepn. of radiopharmaceuticals |
| 09/09/1998 | CN1192695A High affinity human monoclonal antibodies specific for RSV F-protein |
| 09/09/1998 | CN1192693A Therapeutic agent and autoimmune diseases |
| 09/09/1998 | CN1192692A Inhibin compositions and method of enhancing production performance |
| 09/09/1998 | CN1192691A Stable freeze-dried composition contg. TPO |
| 09/09/1998 | CN1192690A Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations |
| 09/09/1998 | CN1192689A Appetite regulating compositions |
| 09/09/1998 | CN1192688A Treatment of HIV and other viral infections using combinatory therapy |
| 09/09/1998 | CN1192686A Method of treatment for lung diseases using antisense oligonucleotides |
| 09/09/1998 | CN1192683A Method for reducing amount of exogenous insulin administered to a patient having noninsulin-dependent diabetes mellitus |
| 09/09/1998 | CN1192376A Compound interferon antiviral drug, prepn. and use thereof |
| 09/08/1998 | US5804688 Compounds and compositions for delivering active agents |
| 09/08/1998 | US5804683 Deprotection of RNA with alkylamine |
| 09/08/1998 | US5804582 Administering immunogenic organic amine salt of n,n'-diacetylcystine |
| 09/08/1998 | US5804578 Useful for treating osteoprosis, catabolic illness, immune deficiency, bone fracture, shrot stature in children, obasity, sleep disorder, cachexia and protein loss due to chronic illness such as aids and cancer |
| 09/08/1998 | US5804566 Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides |
| 09/08/1998 | US5804561 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
| 09/08/1998 | US5804560 Modulates processing of amyloid precursor protein |
| 09/08/1998 | US5804559 Prodrug derivatives of enzyme inhibitors having hydroxyl groups, a process for preparing them, and their use |
| 09/08/1998 | US5804558 Containing disulfide bonds; useful as preservatives and in preventing, treating or ameliorating viral or microbial infections in animals and plants |
| 09/08/1998 | US5804557 Excipient stabilization of polypeptides treated with organic solvents |
| 09/08/1998 | US5804555 Lactoferrin hydrolyzate mixed with oxidation preventing agent(s); food and drug safe |
| 09/08/1998 | US5804554 Calcium channel blocking polypeptides from filistata hibernalis |
| 09/08/1998 | US5804552 Compound consisting of tyrosine or hydroxyproline linked to phospholipid by phosphoester bond through hydroxyl group; capable of conjugation with therapeutic peptide |
| 09/08/1998 | US5804551 Stroma-free modified hemoglobin; improving recovery |
| 09/08/1998 | US5804550 Peptide antagonists at glutamate and NMDA receptors |
| 09/08/1998 | US5804549 Glycerol monolaurate, nisin in the absence of a chelator and a carrier |
| 09/08/1998 | US5804445 High affinity mutants of nuclear factor-interleukin 6 and methods of use therefor |
| 09/08/1998 | US5804440 A deoxypolynucleotide encoding heavy chanin immunologlobulin variable region amino acid residue sequence portion of humans monoclonal antibody which is used in immunotherapy and diagnosis |
| 09/08/1998 | US5804428 Fibrin sealant compositions and methods for utilizing same |
| 09/08/1998 | US5804427 Human mitogen-activated protein kinase kinase polypeptide having serine, threonine, tyrosine activity phosporylates human mitogen-activated protein kinase p38 and human c-jun amino acid kinase |
| 09/08/1998 | US5804419 Encoded by a polynucleotide sequence; forming hybridization complex with nucleic acid material of sample; detecting complex. |
| 09/08/1998 | US5804411 Polypeptide of protein P140 and DNAS encoding it |
| 09/08/1998 | US5804407 Inserting recombinant dna comprising three or more alpha-fetoprotien enhancer and promoter regions, but no silencer region; selective killing of hepatic cancer cells |
| 09/08/1998 | US5804399 Incubation; measuring effect of composition on kinase or polynucleotide encoding the kinase |
| 09/08/1998 | US5804382 Hybridization of amplification-tagged tester dna and non-tagged driver dna in reaction mixture, removal of single-stranded dna and amplification tag prior to amplification of tester-tester homoduplex |
| 09/08/1998 | US5804381 Isolated nucleic acid molecule encoding an esophageal cancer associated antigen, the antigen itself, and uses thereof |
| 09/08/1998 | US5804380 Telomerase activity assays |
| 09/08/1998 | US5804376 Nucleotide and amino acid sequences; expression vector; genetically engineered host cells; diagnostic tests |
| 09/08/1998 | US5804209 Bioadhesive starches and process for their preparation |
| 09/08/1998 | US5804201 Immunomodulatory peptides of vespid antigen 5 |
| 09/08/1998 | US5804200 Parasitic nematode proteins and vaccines |
| 09/08/1998 | US5804196 Self assembled, defective, nonself-propagating viral particles |
| 09/08/1998 | US5804189 Administering polypeptide fragment of cd14 to treat sepsis caused by gramnegative bacterium; competitive binding |
| 09/08/1998 | US5804188 Administering rna polymerase protein |
| 09/08/1998 | US5804187 Modified antibodies with human milk fat globule specificity |
| 09/08/1998 | US5804185 Prevention and treatment of cancer, viral diseases and circulatory system disorders |
| 09/08/1998 | US5804183 Arginine deminase derived from mycoplasma arthritidis and polymer conjugates containing the same |
| 09/08/1998 | US5804181 Pharmaceutical preparation for the prevention and treatment of blood coagulation disorders |
| 09/08/1998 | US5804176 Compositions comprising leukocyte-derived growth factors and methods of administering same to facilitate wound healing |
| 09/08/1998 | US5804159 Antiplasma animal model |
| 09/06/1998 | CA2231012A1 Peptides useful as somatostatin antagonists |
| 09/06/1998 | CA2199325A1 Cyclic analogs of pth and pthrp |
| 09/05/1998 | CA2230965A1 New benzoxazinedione derivatives, a method of producing them and the use thereof |
| 09/03/1998 | WO1998038324A2 Chimeric cell-surface receptors that undergo antigen-induced association |
| 09/03/1998 | WO1998038320A1 Component of bromelain |
| 09/03/1998 | WO1998038319A1 Component of bromelain |
| 09/03/1998 | WO1998038318A1 Factor x deletion mutants and analogues thereof |
| 09/03/1998 | WO1998038317A1 Factor x analogues with a modified protease cleavage site |
| 09/03/1998 | WO1998038312A1 Bacterial elastin binding protein, nucleic acid sequence encoding same and diagnostic and therapeutic methods of use thereof |
| 09/03/1998 | WO1998038310A1 A tm4sf human tumor-associated antigen |